A new study published this week by The British Medical Journal and the US National Institute of Health reveals that high-dose psilocybin may offer benefits in treating depression.

Dried psilocybin mushrooms.
Conducted by a team of researchers from multiple hospitals and universities in Taiwan, the study systematically reviewed and analyzed the performance of various psychedelics, including LSD and MDMA, against escitalopram, a widely used antidepressant.
The study found that while “most psychedelics were better than placebo in psychedelic trials”, only high-dose psilocybin was more effective than placebo in antidepressant trials that included escitalopram.
Continue reading